Nuvo Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRVFF research report →
About the company
Nuvo Pharmaceuticals Inc. , which operates globally under the trade name Miravo Healthcare, specializes in delivering both prescription and over-the-counter medical products. The company's diverse portfolio addresses key therapeutic areas, including pain management, allergy relief, neurological conditions, and dermatological concerns.
- CEO
- Jesse F. Ledger
- IPO
- 2010
- Employees
- 101
- HQ
- Mississauga, ON, CA
Price Chart
- Market Cap
- $11.15M
- P/E
- 10.12
- P/S
- 22.95
- P/B
- 1.49
- EV/EBITDA
- 43.34
- Div Yield
- 0.00%
- Gross Margin
- 51.49%
- Op Margin
- 16.41%
- Net Margin
- 29.38%
- ROE
- 17.08%
- ROIC
- 5.08%
- 52W High
- $1.25
- 52W Low
- $0.42
- 50D MA
- $0.97
- 200D MA
- $0.66
- Beta
- 0.78
- Avg Volume
- 7.78K
Get TickerSpark's AI analysis on MRVFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MRVFF coverage
Recent articles, reports, and earnings notes.
No research on MRVFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRVFF report →Similar companies
Peers in the same neighborhood.